Business Context and Reporting Period
Company: Autolus Therapeutics Plc
Filing Type: Form 8-K (Current Report)
Date of Report: June 5, 2026
Event: Publication of the UK Annual Report and Accounts for the year ended December 31, 2025, and distribution of materials for the Annual General Meeting (AGM) scheduled for June 29, 2026.
Key Financial Metrics
The provided Form 8-K text serves as a notification of the Annual Report's release and does not contain specific financial data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached Exhibit 99.1 (Annual Report and Financial Statements), which is referenced but not included in the source text.
Material Changes
No material financial changes or operational updates are detailed in the body of this 8-K filing. The document solely confirms the dissemination of the 2025 Annual Report and AGM materials to shareholders and American Depositary Share (ADS) holders.
Guidance, Outlook, and Risks
Management Commentary: The filing notes that the Depositary (Citibank, N.A.) will mail voting materials to ADS holders. It includes a caution that the ability to vote may be limited by practical and legal limitations, and ADS holders may not receive materials in time to return instructions.
Legal Status of Information: The information in the attached exhibits (Annual Report, AGM Notice, Proxy Form) is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference unless expressly stated in a future filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Annual Report) for actual 2025 financial performance metrics (revenue, cash burn, R&D expenses).
- Verify the specific resolutions to be voted on at the AGM on June 29, 2026, via the AGM Notice (Exhibit 99.2).
- Confirm the record date for ADS holders (May 27, 2026) and the deadline for submitting voting instructions to Citibank, N.A.
- Check for any updates on clinical trial progress or regulatory milestones within the full Annual Report, as these are not summarized in the 8-K.